Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally

Vaccine. 2021 Jan 15;39(3):596-604. doi: 10.1016/j.vaccine.2020.11.070. Epub 2020 Dec 17.

Abstract

Human hand, foot, and mouth disease (HFMD), an important infectious disease in children, is caused mainly by enterovirus 71 (EV71) and coxsackievirus A16 (CA16). In this study, a bivalent inactivated EV71/CA16 vaccine is developed and evaluated in immunized BALB/c mice injected through the intradermal route. Q-RT-PCR detection of the mRNA of immune signal molecules in local epithelial tissues inoculated with the vaccine indicates activation of innate immunity, which includes upregulation of immune-related chemokines, interferons and CD molecules. Further, the finding that neutralizing antibodies and specific T cellular responses were elicited in adult mice after two immunizations with the vaccine at a 28-day interval, which endowed offspring mice to defend a viral challenge, suggests the successful induction of specific protective antiviral immunity. All these data suggest that immunization with this bivalent EV71/CA16 vaccine via the intradermal route elicits effective immunity against EV71 and CA16 infection.

Keywords: Bivalent vaccine; Coxsackievirus A16; Enterovirus 71; HFMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Enterovirus A, Human*
  • Enterovirus*
  • Hand, Foot and Mouth Disease* / prevention & control
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, Combined
  • Vaccines, Inactivated
  • Viral Vaccines*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Vaccines, Combined
  • Vaccines, Inactivated
  • Viral Vaccines